Malignant Mesothelioma
What's New
Last Posted: Jan 18, 2024
- Serum Calretinin and Genetic Variability as a Prognostic and Predictive Factor in Malignant Mesothelioma.
Cita Zupanc, et al. International journal of molecular sciences 2024 0 (1) - The association of genetic factors with serum calretinin levels in asbestos-related diseases.
Cita Zupanc, et al. Radiology and oncology 2023 0 (4) 473-486 - The role of single nucleotide polymorphisms related to iron homeostasis in mesothelioma susceptibility after asbestos exposure: a genetic study on autoptic samples.
Pierangela Grignani, et al. Frontiers in public health 2023 0 1236558 - Comprehensive bioinformatics analysis of the role of VWF in the tumor microenvironment of malignant mesothelioma.
Jiren Weng, et al. Medicine 2023 0 (41) e35579 - Genetic analysis of familial predisposition in the pathogenesis of malignant pleural mesothelioma.
Akarsu Muhittin, et al. Journal of cancer research and clinical oncology 2023 0 - A study of somatic BRCA variants and their putative effect on protein properties in malignant mesothelioma.
Krishnamurthy Kritika, et al. Pleura and peritoneum 2023 0 (1) 19-25 - Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
Pulford Emily, et al. Disease markers 2017 0 1310478 - Malignant Peripheral Nerve Sheath Tumor in a Patient With BAP1 Tumor Predisposition Syndrome.
Kaszuba Megan C, et al. World neurosurgery 2017 0 362-364 - Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
Ewens K G, et al. BMC cancer 2018 0 (1) 1172 - Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.
Potjer Thomas P, et al. International journal of cancer 2018 0 (10) 2453-2464
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: